Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).

Stopped Study terminated due to discontinuation of the AZD4041 clinical development program for OUD.

Conditions

• Opioid Use Disorder

Interventions

• DRUG: AZD4041
• DRUG: Itraconazole
• DRUG: Buprenorphine
• DRUG: Buprenorphine / Naloxone
• DRUG: Hydromorphone
• DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

• [object Object]